Imugene Financial Statements From 2010 to 2024

Stocks . Australia . 
Stock . Imugene
IMU Stock   0.04  0  5.26%   
Imugene financial statements provide useful quarterly and yearly information to potential Imugene investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Imugene financial statements helps investors assess Imugene's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Imugene's valuation are summarized below:
Gross Profit
11.8 M
Market Capitalization
302.7 M
Revenue
5 M
Earnings Share
(0.02)
Quarterly Revenue Growth
0.676
There are currently ninety-one fundamental trends for Imugene that can be evaluated and compared over time across competitors. All traders should confirm Imugene's regular fundamentals against the performance from 2010 to 2024 and make sure the trends continue to evolve in the right direction.

Imugene Total Revenue

14.22 Million

Check Imugene financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Imugene's main balance sheet or income statement drivers, such as Depreciation And Amortization of 6.1 M, Interest Expense of 502.3 K or Other Operating Expenses of 148 M, as well as many indicators such as . Imugene financial statements analysis is a perfect complement when working with Imugene Valuation or Volatility modules.
  
This module can also supplement various Imugene Technical models . Check out the analysis of Imugene Correlation against competitors.

Imugene Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets159 M151.4 M59.3 M
Slightly volatile
Short and Long Term Debt Total1.6 M1.5 M911.1 K
Pretty Stable
Other Current Liabilities23.5 M22.4 M4 M
Slightly volatile
Total Current Liabilities30.8 M29.3 M5.8 M
Slightly volatile
Total Stockholder Equity124.2 M118.3 M52 M
Slightly volatile
Property Plant And Equipment Net1.8 M1.7 M395.3 K
Slightly volatile
Accounts Payable6.3 M6 M1.6 M
Slightly volatile
Cash97.8 M93.1 M36.1 M
Slightly volatile
Non Current Assets Total40.3 M38.4 M17.2 M
Slightly volatile
Cash And Short Term Investments99.3 M94.5 M36.3 M
Slightly volatile
Net Receivables13.2 M12.6 M4.7 M
Slightly volatile
Common Stock Total Equity126.7 M120.6 M62 M
Slightly volatile
Common Stock Shares Outstanding7.4 B7.1 B3.1 B
Slightly volatile
Liabilities And Stockholders Equity159 M151.4 M59.3 M
Slightly volatile
Non Current Liabilities Total4 M3.8 M1.5 M
Slightly volatile
Total Liabilities34.8 M33.1 M7.3 M
Slightly volatile
Property Plant And Equipment Gross2.8 M2.6 M590.1 K
Slightly volatile
Total Current Assets118.7 M113 M42 M
Slightly volatile
Accumulated Other Comprehensive Income39.7 M37.8 M9.8 M
Slightly volatile
Intangible Assets35.8 M34.1 M16.4 M
Slightly volatile
Common Stock388.8 M370.3 M118.2 M
Slightly volatile
Good Will2 M1.1 M978.8 K
Slightly volatile
Other Liabilities1.1 M1.1 M1.1 M
Slightly volatile
Short and Long Term Debt1.5 M1.4 M1.2 M
Slightly volatile
Property Plant Equipment645.4 K614.7 K365.7 K
Pretty Stable
Long Term Debt852 K1.1 M930.2 K
Slightly volatile
Other Current Assets6.2 M5.9 M1.3 M
Slightly volatile
Non Current Liabilities Other4 M3.8 M1.6 M
Slightly volatile
Long Term Debt Total462.4 K326.2 K716.5 K
Slightly volatile
Net Invested Capital85.8 M118.3 M51.9 M
Slightly volatile
Cash And Equivalents59.8 M57 M20 M
Slightly volatile
Net Working Capital61.6 M83.7 M36.3 M
Slightly volatile
Other Assets0.860.913.8 K
Slightly volatile
Capital Lease Obligations371.8 K636.5 K245.4 K
Slightly volatile
Capital Stock219.4 M370.3 M128.1 M
Slightly volatile

Imugene Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization6.1 M5.8 M1.4 M
Slightly volatile
Other Operating Expenses148 M140.9 M31.1 M
Slightly volatile
Total Operating Expenses141.8 M135.1 M29.8 M
Slightly volatile
Total Revenue14.2 M13.5 M5 M
Slightly volatile
Selling General Administrative47.3 M45 M10.2 M
Slightly volatile
Research Development91.2 M86.9 M19.5 M
Slightly volatile
Selling And Marketing Expenses305.7 K582.5 K310.2 K
Slightly volatile
Interest Income4.7 M4.5 M846.8 K
Slightly volatile
Net Interest Income4.2 M4 M752.2 K
Slightly volatile
Reconciled Depreciation3.5 M3.3 M493.4 K
Slightly volatile

Imugene Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Depreciation6.1 M5.8 M1.3 M
Slightly volatile
Total Cash From Financing Activities51.9 M49.4 M24.6 M
Slightly volatile
Change To Netincome4.4 M4.2 M2.2 M
Slightly volatile
Stock Based Compensation6.8 M6.5 M2.1 M
Slightly volatile
Issuance Of Capital Stock57.5 M53.7 M35.5 M
Slightly volatile

Imugene Fundamental Market Drivers

Cash And Short Term Investments94.5 M

About Imugene Financial Statements

Imugene shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although Imugene investors may analyze each financial statement separately, they are all interrelated. The changes in Imugene's assets and liabilities, for example, are also reflected in the revenues and expenses on on Imugene's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Current Deferred Revenue1.9 M2 M
Total Revenue13.5 M14.2 M
Cost Of Revenue5.8 M6.1 M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Imugene Stock Analysis

When running Imugene's price analysis, check to measure Imugene's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Imugene is operating at the current time. Most of Imugene's value examination focuses on studying past and present price action to predict the probability of Imugene's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Imugene's price. Additionally, you may evaluate how the addition of Imugene to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY